- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-1827
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cannabinoids as anticancer drugs: current status of preclinical research ; volume:127 ; number:1 ; day:11 ; month:3 ; year:2022 ; pages:1-13 ; date:7.2022
British journal of cancer ; 127, Heft 1 (11.3.2022), 1-13, 7.2022
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41416-022-01727-4
- URN
-
urn:nbn:de:101:1-2022091501481883764549
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:19 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hinz, Burkhard
- Ramer, Robert Georg
- SpringerLink (Online service)
Ähnliche Objekte (12)
Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
Cannabinoids
Current advances of anticancer drugs based on solubilization technology
New anticancer drugs
Metabolomics in Preclinical Drug Safety Assessment : Current Status and Future Trends
Cannabinoids as therapeutics
Pharmacogenetics of Cannabinoids
Cannabinoids as Cocrystals
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
CDK7 inhibitors as anticancer drugs
Empagliflozin: a potential anticancer drug
In silico investigation of cannabinoids from Cannabis sativa leaves as a potential anticancer drug to inhibit MAPK-ERK signaling pathway and EMT induction
Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
Cannabinoids
Current advances of anticancer drugs based on solubilization technology
New anticancer drugs
Metabolomics in Preclinical Drug Safety Assessment : Current Status and Future Trends
Cannabinoids as therapeutics
Pharmacogenetics of Cannabinoids
Cannabinoids as Cocrystals
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
CDK7 inhibitors as anticancer drugs
Empagliflozin: a potential anticancer drug
In silico investigation of cannabinoids from Cannabis sativa leaves as a potential anticancer drug to inhibit MAPK-ERK signaling pathway and EMT induction
Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
Cannabinoids
Current advances of anticancer drugs based on solubilization technology
New anticancer drugs
Metabolomics in Preclinical Drug Safety Assessment : Current Status and Future Trends
Cannabinoids as therapeutics
Pharmacogenetics of Cannabinoids
Cannabinoids as Cocrystals
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
CDK7 inhibitors as anticancer drugs
Empagliflozin: a potential anticancer drug